From Name:
From Email:
To Name:
To Email:

Optional Message:


SCAI Supports Alliance of Specialty Medicine Testimony on Off-label Use of Approved Medical Products

from SCAI

At a public hearing later this month, the Alliance of Specialty Medicine (in which SCAI is a member) will provide testimony to the Food and Drug Administration surrounding concerns about regulations that limit communications regarding off-label use of approved medical products. The Alliance believes the FDA's current regulations unnecessarily interfere with the dissemination of scientifically valid information between healthcare professionals and manufacturers. This interference, as the Alliance states, would ultimately deny physicians access to vital, current, real-world experiences and adversely affects healthcare outcomes.

Read the full testimony here. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063